There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Zylem Biosciences announced that Northwestern University has filed a lawsuit against Moderna (MRNA), alleging infringement of key patents ...

Because of these changes, JN1 has a higher transmission potential and some resistance to earlier vaccines. Moderna’s new ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...